Article Versions Notes

Gurba-Bryśkiewicz L, Dawid U, Smuga DA, Maruszak W, Delis M, Szymczak K, Stypik B, Moroz A, Błocka A, Mroczkiewicz M, et al. Implementation of QbD Approach to the Development of Chromatographic Methods for the Determination of Complete Impurity Profile of Substance on the Preclinical and Clinical Step of Drug Discovery Studies. International Journal of Molecular Sciences. 2022; 23(18):10720. https://doi.org/10.3390/ijms231810720

Gurba-Bryśkiewicz, Lidia, Urszula Dawid, Damian A. Smuga, Wioleta Maruszak, Monika Delis, Krzysztof Szymczak, Bartosz Stypik, Aleksandra Moroz, Aleksandra Błocka, Michał Mroczkiewicz, and et al. 2022. "Implementation of QbD Approach to the Development of Chromatographic Methods for the Determination of Complete Impurity Profile of Substance on the Preclinical and Clinical Step of Drug Discovery Studies" International Journal of Molecular Sciences 23, no. 18: 10720. https://doi.org/10.3390/ijms231810720

Gurba-Bryśkiewicz, L., Dawid, U., Smuga, D. A., Maruszak, W., Delis, M., Szymczak, K., Stypik, B., Moroz, A., Błocka, A., Mroczkiewicz, M., Dubiel, K., & Wieczorek, M. (2022). Implementation of QbD Approach to the Development of Chromatographic Methods for the Determination of Complete Impurity Profile of Substance on the Preclinical and Clinical Step of Drug Discovery Studies. International Journal of Molecular Sciences, 23(18), 10720. https://doi.org/10.3390/ijms231810720